AU2002236587A1 - Compositions for adhesion prevention - Google Patents
Compositions for adhesion preventionInfo
- Publication number
- AU2002236587A1 AU2002236587A1 AU2002236587A AU3658702A AU2002236587A1 AU 2002236587 A1 AU2002236587 A1 AU 2002236587A1 AU 2002236587 A AU2002236587 A AU 2002236587A AU 3658702 A AU3658702 A AU 3658702A AU 2002236587 A1 AU2002236587 A1 AU 2002236587A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- adhesion prevention
- administration
- formulations
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000002265 prevention Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000002894 organic compounds Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Sealing Material Composition (AREA)
- Macromonomer-Based Addition Polymer (AREA)
Abstract
Compositions and methods for the prevention of adhesion development involve the administration of therapeutic formulations of a halogenated organic compound to a patient in need of treatment. The formulations can include suitable carriers for optimal administration.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25229700P | 2000-11-21 | 2000-11-21 | |
US60/252,297 | 2000-11-21 | ||
PCT/US2001/047362 WO2002041841A2 (en) | 2000-11-21 | 2001-11-16 | Compositions for adhesion prevention |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002236587A1 true AU2002236587A1 (en) | 2002-06-03 |
Family
ID=22955426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002236587A Abandoned AU2002236587A1 (en) | 2000-11-21 | 2001-11-16 | Compositions for adhesion prevention |
Country Status (7)
Country | Link |
---|---|
US (1) | US6518308B2 (en) |
EP (1) | EP1347754B1 (en) |
AT (1) | ATE371446T1 (en) |
AU (1) | AU2002236587A1 (en) |
CA (1) | CA2429624A1 (en) |
DE (1) | DE60130253D1 (en) |
WO (1) | WO2002041841A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7758654B2 (en) * | 2004-05-20 | 2010-07-20 | Kensey Nash Corporation | Anti-adhesion device |
EP1915169A2 (en) * | 2005-07-12 | 2008-04-30 | Renovo Limited | Pharmaceutical compositions comprising a tgf-beta superfamily member |
US20090269390A1 (en) * | 2008-04-25 | 2009-10-29 | Medtronic, Inc. | Medical devices, polymers, compositions, and methods for delivering a haloacetate |
AU2010229042A1 (en) * | 2009-03-23 | 2011-11-10 | Kross-Link Laboratories | Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE456346B (en) | 1984-07-23 | 1988-09-26 | Pharmacia Ab | GEL TO PREVENT ADHESION BETWEEN BODY TISSUE AND SET FOR ITS PREPARATION |
US4819617A (en) | 1986-09-04 | 1989-04-11 | University Of Florida | Viscoelastic material for ophthalmic surgery |
WO1995024929A2 (en) | 1994-03-15 | 1995-09-21 | Brown University Research Foundation | Polymeric gene delivery system |
EP0840623B1 (en) | 1995-07-21 | 2007-07-18 | Brown University Research Foundation | Compositions for gene therapy comprising nucleic acid loaded polymeric microparticles |
US6011017A (en) * | 1998-04-15 | 2000-01-04 | Cypros Pharmaceutical Corp. | Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass |
CA2354863A1 (en) | 1998-10-02 | 2000-04-13 | University Of Florida | Prevention of adhesions |
US6211217B1 (en) * | 1999-03-16 | 2001-04-03 | Novartis Ag | Method for reducing pericardial fibrosis and adhesion formation |
US6579889B2 (en) * | 2000-06-22 | 2003-06-17 | Merck & Co., Inc. | Substituted isonipecotyl derivatives as inhibitors of cell adhesion |
-
2001
- 2001-11-16 AT AT01986122T patent/ATE371446T1/en not_active IP Right Cessation
- 2001-11-16 EP EP01986122A patent/EP1347754B1/en not_active Expired - Lifetime
- 2001-11-16 DE DE60130253T patent/DE60130253D1/en not_active Expired - Lifetime
- 2001-11-16 US US10/012,711 patent/US6518308B2/en not_active Expired - Fee Related
- 2001-11-16 WO PCT/US2001/047362 patent/WO2002041841A2/en active IP Right Grant
- 2001-11-16 AU AU2002236587A patent/AU2002236587A1/en not_active Abandoned
- 2001-11-16 CA CA002429624A patent/CA2429624A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002041841A3 (en) | 2002-10-31 |
EP1347754A2 (en) | 2003-10-01 |
US6518308B2 (en) | 2003-02-11 |
EP1347754B1 (en) | 2007-08-29 |
WO2002041841A2 (en) | 2002-05-30 |
US20020068762A1 (en) | 2002-06-06 |
DE60130253D1 (en) | 2007-10-11 |
EP1347754A4 (en) | 2004-10-13 |
ATE371446T1 (en) | 2007-09-15 |
CA2429624A1 (en) | 2002-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7031500A (en) | Therapeutic quinazoline compounds | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
NZ514574A (en) | Novel method of treatment | |
AU5986200A (en) | Compounds | |
AU2623201A (en) | Controlled delivery of therapeutic agents by insertable medical devices | |
AU6825300A (en) | Compounds | |
HK1064921A1 (en) | Sustained release formulations of oxymorphone | |
AU1200501A (en) | Drug delivery catheters that attach to tissue and methods for their use | |
AU2274201A (en) | Compounds and compositions for delivering active agents | |
NZ516347A (en) | Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them | |
AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
AU3850600A (en) | Dalda analogs and their use | |
AU2002214389A1 (en) | Pharmaceutical composition containing honey for the treatment of wounds | |
AU1262501A (en) | Compositions for transdermal and transmucosal administration of therapeutic agents | |
AU2000255628A1 (en) | Formulation comprising thymol useful in the treatment of drug resistant bacterial infections | |
IL143985A0 (en) | New use of melagatran | |
CA2417935A1 (en) | Anti-inflammatory medicament | |
GB9907571D0 (en) | Compounds | |
AU2003290015A1 (en) | Mastitis treatment | |
AU2420001A (en) | Methods and compositions for the treatment of pain | |
AU2002236587A1 (en) | Compositions for adhesion prevention | |
AU2001267561A1 (en) | Combination preparations of 3-n-formylhydroxylaminopropyl phosphonic acid derivatives or 3-n-acetylhydroxylaminopropyl phosphonic acid derivatives combined withspecific pharmaceutical active agents | |
AU2173101A (en) | Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents | |
MXPA01012936A (en) | Pharmaceutical composition containing sibutramine and orlistat. |